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arising from the tongueHiroshi Yamazaki a,*, Keiichi Tsukinoki b,
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Kanagawa 259-1193, JapanReceived 12 January 2005; accepted 22 January 2005Summary Malignant peripheral nerve sheath tumor (MPNST) is a rare malignant
tumor that develops in soft tissues and MPNST with perineurial cell differentiation
(perineurial MPNST) is a subtype of this tumor. This case report describes a 24-
year-old Japanese male with perineurial MPNST arising at the root of the tongue.
The tumor was diagnosed by immunohistochemical and ultrastructural techniques,
and was treated by partial glossectomy. No signs of recurrence or metastasis have
been observed for more than 2 years postoperatively. As far as we know, this is
the first case report of perineurial MPNST arising in the oral cavity.c 2005 Elsevier Ltd. All rights reserved.
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5Introduction
Malignant peripheral nerve sheath tumor (MPNST)
is a rare histological variant that develops in soft
tissue. Although it was previously reported as
malignant schwannoma, recently it has been recog-741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights rese
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E-mail address: osyamaza@nifty.com (H. Yamazaki).nized as a different entity. Immunohistochemical
studies have revealed that it has many variations.
MPNST with perineurial cell differentiation (peri-
neurial MPNST) is a recently reported a subtype
of MPNST that is characterized by being EMA posi-
tive and S-100 protein negative on immunostain-
ing.1 The present paper reports the first case of
perineurial MPNST arising from the tongue that
was diagnosed by ultrastructural and immunohisto-
chemical techniques.rved.
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A 24 year-old Japanese male was referred to our
department in April 2002 with a 12 mm painless
swelling in the left side of the tongue which he
had firstly noticed about 3 weeks earlier. His med-
ical history was unremarkable. There was no docu-
mented evidence of von Recklinghausen’s disease
in the family. Physical examination was unremark-
able except in the region of the left tongue. The
tumor was covered by normal-appearing mucosa,
with no ulceration or inflammation. On palpation,
the lesion was firm and no fluctuant (Fig. 1A). No
paresthesia or impaired movement of the tongue
was observed. The cervical lymph nodes were not
enlarged. MRI showed a well-defined mass at the
left lingual root (Fig. 1B). Open biopsy gave a diag-
nosis of irritation fibroma. Since the tumor had
grown outward from the biopsy site, it was sus-
pected to be malignant. Partial glossectomy was
performed under general anesthesia (Fig. 1C).
Pathologic examination of the resected tissue
showed that the mass was perineurial MPNST.
No tumor cells were observed at the resection mar-
gin. The postoperative course has been uneventful
with no recurrence or metastasis for more than 2
years.Figure 1 (A) Intraoral finding. A tumor with a diameter of
the tongue. It is grayish white, elastic, and hard. (B) MRI fin
tumor with a diameter of 1 cm at the left lingual root. The
Operative photograph. The tumor has grown outward from th
white tumor without fibrous capsule.Pathologic findings
Macroscopically, a yellowish-white tumor measur-
ing 30 · 15 mm in size was located at the left bor-
der of the tongue (Fig. 1D). The tumor was solid
without areas of necrosis or hemorrhage. Sections
taken from the resected mass showed the prolifer-
ation of spindle-shaped cells with elongated or
pleomorphic nuclei and mild atypia (Fig. 2A and
B). Mitotic figures were frequently observed (Fig.
2B). The tumor showed fascicles of nuclear palisad-
ing with features mimicking Verocay bodies or cells
arranged in a striform pattern. These cells also
showed focal invasion of the surrounding soft tis-
sues and blood vessels (Fig. 2C). Immunohisto-
chemical staining was performed using an
improved streptoavidin-biotin peroxidase complex
technique. The tumor cells were S-100-negative,
SMA-negative, and focally type IV collagen-posi-
tive. Strong immunoreactivity for EMA was demon-
strated by many of the tumor cells (Fig. 2D). The
MIB-1 labeling index was 40% (Fig. 2E). Electron
micrographs showed a basal lamina focally sur-
rounding the tumor cells. Tight junctions were
sometimes seen between the cells and pinocytic
vesicles were observed in the cells (Fig. 3). These
findings gave a diagnosis of perineurial MPNST.1 cm is observed at the papilla vallata on the left side of
ding. T1 Weighed MRI-Gd shows a relatively well defined
internal architecture seems to be almost uniform. (C)
e biopsy site. (D) Macrophotograph showing a yellowish-
Figure 2 Microscopic and immunohistochemical findings. (A) Low-power view of the tumor showing invasion into the
surrounding soft tissue (hematoxylin-eosin, ·10). (B) High-power view showing proliferation of spindle-shaped cells
with elongated or pleomorphic nuclei and mild atypia. Mitotic figures are frequently observed (hematoxylin-eosin,
·100). (C) Apparent invasion into the blood vessel are seen (hematoxylin-eosin, ·100). (D) Microphotograph showing
EMA positivity in the tumor cells (·100). (E) MIB-1 labeling index is high (·66).
Figure 3 Electron micrograph showing pinocytic vesi-
cles in the tumor cells.
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MPNST is a malignancy that arises from a peripheral
nerve or differentiates into peripheral nerve. It is
relatively rare and only accounts for 5–10% of all
soft tissue sarcomas.2 Although 8–16% of MPNSTs
develop in the head and neck region, MPNSTs are
extremely rare in the oral cavity.3 Histologically,
MPNST is classified into the typical type and various
subtypes. Perineurial MPNST is a rare subtype of
MPNST. Hirose et al. reported that only 5 out of
121 MPNST patients (4%) had perineurial MPNST.4
In addition, the article by Rosenberg et al. contains
an excellent review of the documented cases of
perineurial MPNST.5 To the best of our knowledge,
a total of 13 cases of perineurial MPNST have been
reported, including 8 males and 5 females aged
11–83 years old (mean age: 52.9 years).1,4–10 The
location of the tumor was the back,1,4 mediastinum,4
80 H. Yamazaki et al.retroperitoneum,4 face,4 thigh,4 arm,5,6 chest
wall,7 pancreas,8 paravertebral column,9 and pelvic
soft tissues.10 Five of the 13 patients (38.5%) had
local recurrence and 4 (30.8%) had distant metasta-
sis. None of the 13 reported cases of perineurial
MPNST reviewed in the present study arose in the
oral cavity. Therefore, the present patient is the
first reported case of perineurial MPNST in the oral
cavity.
Perineurial MPNST is histologically formed of
spindle-shaped cells with relatively homogeneous
nuclei and bipolar slender processes that prolifer-
ate densely in whorls or a storiform pattern. Immu-
nohistochemical analyses also supported
perineurial cell differentiation of the present tu-
mor. None of the tumor cells reacted with S-100
protein antibody, whereas many were positive for
EMA. S-100 protein is recognized as a marker for
schwann cells in normal peripheral nerves and
nerve sheath tumors. On the other hand, EMA is
considered to be a marker for perineurial cells as
well as epithelial cells. Its presence has been re-
ported in the normal perineurium and in several
types of peripheral nerve sheath tumors, including
benign perineuriomas and perineurial MPNSTs. Em-
ory et al. reported that the MIB-1 labeling index of
intraneural perineurioma ranged from 3.7% to 17%
(mean: 7.4%), 11 while Hirose et al. reported that
the MIB-1 labeling index of perineurial MPNST ran-
ged from 6.9% to 29.8% (mean: 14.9%, median:
10.7%).4 In the present case, the MIB-1 labeling in-
dex was 40%. It was decided that the tumor was
malignant because of the high MIB-1 labeling index,
the presence of atypical mitotic figures, and areas
of invasion.
Typical MPNST is associated with frequent local
recurrence or distant metastasis, like other highly
malignant sarcomas; its local recurrence rate
ranges from 40% to 42%12,13 and 65% of patients suf-
fer from distant metastasis to the lungs or bone.13
Typical MPNST has been reported to have a 5-year
survival rate of 34–39%.12,13 Perineurial MPNST is
also associated with local recurrence or distant
metastasis, but is considered to have a better prog-
nosis than typical MPNST.4 The present case has
shown no signs of recurrence or metastasis for
more than 2 years postoperatively. Although the
postoperative course has been uneventful, it will
be necessary to follow him closely.Acknowledgement
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